annb0t
Top 20
Boston Scientific BSX has announced plans to acquire carotid artery device specialist Silk Road Medical for approximately $1.26 billion. This is a strategic move poised to significantly expand the companyâs cardiology portfolio.
By paying $27.50 per share, Boston Scientific is offering a 38% premium over Silk Road's volume-weighted average share price over the past 60 days. With this transaction, expected to close in the second half of 2024, Silk Road will become a wholly owned subsidiary ...
>>> Read more: Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
By paying $27.50 per share, Boston Scientific is offering a 38% premium over Silk Road's volume-weighted average share price over the past 60 days. With this transaction, expected to close in the second half of 2024, Silk Road will become a wholly owned subsidiary ...
>>> Read more: Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
